Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs
TOKYO, May 17, 2023 – (JCN Newswire via SEAPRWire.com) – Fujitsu Limited, Kyoto University (1), Chordia Therapeutics, Inc. (2), today announced the beginning of field trials leveraging Fujitsu’s AI causal discovery technology to shed light on biomarkers (3) that increase the probability of success or shorten the duration of clinical trials in the development of […]